Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies (Tables)

v3.26.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2026
Accounting Policies [Abstract]  
Summary of Revisions to Previously Issued Financial Statements

The following tables reflect the revisions to the previously issued Condensed Consolidated Statements of Operations for the three months ended March 31, 2026:

 

 

 

Three Months Ended March 31, 2026

 

 

 

As Previously Reported

 

 

Adjusted

 

 

As Revised

 

 

 

(In thousands)

 

Cost of revenue

 

 

 

 

 

 

 

 

 

3D Printer and parts

 

$

10,225

 

 

$

(989

)

 

$

9,236

 

Total cost of revenue

 

 

11,435

 

 

 

(989

)

 

 

10,446

 

Gross profit

 

 

2,381

 

 

 

989

 

 

 

3,370

 

Operating expenses

 

 

 

 

 

 

 

 

 

Research and development

 

 

2,695

 

 

 

254

 

 

 

2,949

 

Total operating expenses

 

 

9,328

 

 

 

254

 

 

 

9,582

 

Loss from operations

 

 

(6,947

)

 

 

735

 

 

 

(6,212

)

Loss before income taxes

 

 

(6,972

)

 

 

735

 

 

 

(6,237

)

Net loss

 

$

(6,998

)

 

$

735

 

 

$

(6,263

)

Net loss per share:

 

 

 

 

 

 

 

 

 

    Basic and Diluted

 

$

(0.28

)

 

$

0.03

 

 

$

(0.25

)

 

The following tables reflects the revisions to the previously issued Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2026:

 

 

 

Three Months Ended June 30, 2026

 

 

Six Months Ended June 30, 2026

 

 

 

As Previously Reported

 

 

Adjusted

 

 

As Revised

 

 

As Previously Reported

 

 

Adjusted

 

 

As Revised

 

 

 

(In thousands)

 

 

(In thousands)

 

Cost of revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3D Printer and parts

 

$

15,755

 

 

$

(1,138

)

 

$

14,617

 

 

$

25,980

 

 

$

(2,127

)

 

$

23,853

 

Total cost of revenue

 

 

16,222

 

 

 

(1,138

)

 

 

15,084

 

 

 

27,657

 

 

$

(2,127

)

 

 

25,530

 

Gross profit

 

 

4,442

 

 

 

1,138

 

 

 

5,580

 

 

 

6,823

 

 

 

2,127

 

 

 

8,950

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

4,329

 

 

 

281

 

 

 

4,610

 

 

 

7,024

 

 

 

535

 

 

 

7,559

 

Total operating expenses

 

 

15,503

 

 

 

281

 

 

 

15,784

 

 

 

24,831

 

 

 

535

 

 

 

25,366

 

Loss from operations

 

 

(11,061

)

 

 

857

 

 

 

(10,204

)

 

 

(18,008

)

 

 

1,592

 

 

 

(16,416

)

Loss before income taxes

 

 

(11,519

)

 

 

857

 

 

 

(10,662

)

 

 

(18,491

)

 

 

1,592

 

 

 

(16,899

)

Net loss

 

$

(11,510

)

 

$

857

 

 

$

(10,653

)

 

$

(18,508

)

 

$

1,592

 

 

$

(16,916

)

Net loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Basic and Diluted

 

$

(0.39

)

 

$

0.03

 

 

$

(0.36

)

 

$

(0.68

)

 

$

0.06

 

 

$

(0.62

)

The following table reflects the revisions to the previously issued Condensed Consolidated Balance Sheets as of March 31, 2026 and June 30, 2026:

 

 

 

As of March 31, 2026

 

 

As of June 30, 2026

 

 

 

As Previously Reported

 

 

Adjusted

 

 

As Revised

 

 

As Previously Reported

 

 

Adjusted

 

 

As Revised

 

 

 

(In thousands)

 

 

(In thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventories, net

 

$

28,104

 

 

$

735

 

 

$

28,839

 

 

$

27,578

 

 

$

1,592

 

 

$

29,170

 

Total current assets

 

$

65,170

 

 

$

735

 

 

$

65,905

 

 

$

156,134

 

 

$

1,592

 

 

$

157,726

 

Total assets

 

$

92,404

 

 

$

735

 

 

$

93,139

 

 

$

200,147

 

 

$

1,592

 

 

$

201,739

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated deficit

 

$

(505,141

)

 

$

735

 

 

$

(504,406

)

 

$

(516,651

)

 

$

1,592

 

 

$

(515,059

)

Total stockholders’ equity

 

$

51,540

 

 

$

735

 

 

$

52,275

 

 

$

146,539

 

 

$

1,592

 

 

$

148,131

 

Total liabilities and stockholders’ equity

 

$

92,404

 

 

$

735

 

 

$

93,139

 

 

$

200,147

 

 

$

1,592

 

 

$

201,739

 

 

The following table reflects the revisions to the previously issued Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and the six months ended June 30, 2026:

 

 

 

Three Months Ended March 31, 2026

 

 

Six Months Ended June 30, 2026

 

 

 

As Previously Reported

 

 

Adjusted

 

 

As Revised

 

 

As Previously Reported

 

 

Adjusted

 

 

As Revised

 

 

 

(In thousands)

 

 

(In thousands)

 

Cash flows from operating activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(6,998

)

 

$

735

 

 

$

(6,263

)

 

$

(18,508

)

 

$

1,592

 

 

$

(16,916

)

Adjustments to reconcile net loss to net cash used in operating activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reserve for excess and obsolete inventory

 

$

—

 

 

$

390

 

 

$

390

 

 

$

—

 

 

$

857

 

 

$

857

 

Changes in operating assets and liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inventories

 

$

672

 

 

$

(1,125

)

 

$

(453

)

 

$

4,441

 

 

$

(2,449

)

 

$

1,992